Optipharm Pharmaceuticals Limited in Middlesex, HA9 9AB

Description

Data updated on: 01-11-2023

This particular Optipharm Pharmaceuticals Limited company has been operating in this business field for 23 years, as it's been founded in 2001. Registered with number 04311794, Optipharm Pharmaceuticals was set up as a Private Limited Company located in 29 Bridge Road, Middlesex HA9 9AB. The enterprise's declared SIC number is 47730 which stands for Dispensing chemist in specialised stores. Optipharm Pharmaceuticals Ltd filed its account information for the period up to Sat, 31st Dec 2022. The most recent annual confirmation statement was submitted on Mon, 9th Oct 2023.

According to the information we have, the following company was formed in October 2001 and has so far been supervised by two directors. In order to provide support to the directors, the abovementioned company has been utilizing the skills of Maryam B. as a secretary since 2001.

Executives who control the firm include: Lateef B. owns 1/2 or less of company shares. Maryam B. owns 1/2 or less of company shares.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2011-10-31	2012-10-31	2013-10-31	2014-10-31	2015-10-31	2016-10-31	2017-10-31	2018-10-31	2019-10-31	2020-12-31	2021-12-31	2022-12-31
Currency
Net Worth	-53 477	-34 807	-27 886

Balance Sheet
Cash Bank On Hand									100	100	100	100
Current Assets	62 176	56 653	55 043	56 265	57 175	51 107	80 095	70 925	50 439
Net Assets Liabilities						8 831	22 933	33 991	100	100	100	100
Cash Bank In Hand			-4 956	-5 365	-5 687	-5 014
Debtors	44 269	38 192	36 223	42 810	46 340	41 120
Net Assets Liabilities Including Pension Asset Liability	-53 477	-34 807	-27 886	-13 339	-5 749	8 317
Intangible Fixed Assets	1 367	217
Stocks Inventory	17 907	18 461	18 820	18 820	16 522	15 001
Tangible Fixed Assets		217	117	17	922	3 132

Capital & Reserves
Called Up Share Capital	100	100	100	100	100	100
Profit Loss Account Reserve	-53 577	-34 906	-27 986	-16 280	-5 849	8 217
Shareholder Funds	-53 477	-34 807	-27 886

Other Financial Data
Average Number Employees During Period								1	1
Creditors						40 157	39 385	30 441	46 337
Fixed Assets	1 367	217	117			3 132	2 332	1 532
Net Current Assets Liabilities	21 208	20 258	13 695	19 527	18 657	15 964	40 710	40 484	4 102
Number Shares Allotted										100	100	100
Par Value Share				1	1	1				1	1	1
Total Assets Less Current Liabilities	22 575	20 475	13 111	19 544	17 285	19 096	43 042	42 016	4 102
Capital Employed			-24 796	-16 180	-5 749	8 317
Creditors Due After One Year	76 052	55 282	41 698	35 724	25 100	10 037
Creditors Due Within One Year	40 968	36 395	41 348	33 187	38 518	35 143
Provisions For Liabilities Charges					228	742
Intangible Fixed Assets Aggregate Amortisation Impairment	12 370	13 520
Intangible Fixed Assets Amortisation Charged In Period		1 150
Intangible Fixed Assets Cost Or Valuation	13 737	13 737
Tangible Fixed Assets Cost Or Valuation		13 737	13 737	13 737	14 879	17 889
Tangible Fixed Assets Depreciation		13 520	13 620	13 720	13 957	14 757
Tangible Fixed Assets Depreciation Charged In Period			100		237	800
Share Capital Allotted Called Up Paid			100	100	100	100
Tangible Fixed Assets Additions					1 142	3 010

Company staff

Lateef B.

Role: Director

Appointed: 30 October 2001

Latest update: 21 March 2024

Maryam B.

Role: Director

Appointed: 30 October 2001

Latest update: 21 March 2024

Maryam B.

Role: Secretary

Appointed: 30 October 2001

Latest update: 21 March 2024

People with significant control

Lateef B.

Notified on 1 October 2016

Nature of control:

1/2 or less of shares

Maryam B.

Notified on 1 October 2016

Nature of control:

1/2 or less of shares

Accounts Documents

Account next due date	30 September 2024
Account last made up date	31 December 2022
Confirmation statement next due date	23 October 2024
Confirmation statement last made up date	09 October 2023

Annual Accounts 25 July 2013
Start Date For Period Covered By Report	2011-11-01
End Date For Period Covered By Report	2012-10-31
Date Approval Accounts	25 July 2013
Annual Accounts 30 July 2014
Start Date For Period Covered By Report	2012-11-01
End Date For Period Covered By Report	2013-10-31
Date Approval Accounts	30 July 2014
Annual Accounts 28 July 2016
Start Date For Period Covered By Report	2014-11-01
End Date For Period Covered By Report	31 October 2015
Date Approval Accounts	28 July 2016
Annual Accounts 28 July 2017
Start Date For Period Covered By Report	2015-11-01
End Date For Period Covered By Report	31 October 2016
Date Approval Accounts	28 July 2017
Annual Accounts
Start Date For Period Covered By Report	2016-11-01
End Date For Period Covered By Report	2017-10-31
Annual Accounts
Start Date For Period Covered By Report	2017-11-01
End Date For Period Covered By Report	2018-10-31
Annual Accounts
Start Date For Period Covered By Report	2018-11-01
End Date For Period Covered By Report	2019-10-31
Annual Accounts
Start Date For Period Covered By Report	2019-11-01
End Date For Period Covered By Report	2020-12-31
Annual Accounts
Start Date For Period Covered By Report	2021-01-01
End Date For Period Covered By Report	2021-12-31
Annual Accounts
Start Date For Period Covered By Report	2022-01-01
End Date For Period Covered By Report	2022-12-31
Annual Accounts 30 July 2015
End Date For Period Covered By Report	31 October 2014
Date Approval Accounts	30 July 2015

Optipharm Pharmaceuticals Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Lateef B.

Maryam B.

Maryam B.

Bloomsbury Secretaries Limited

Bloomsbury Directors Limited

People with significant control

Lateef B.

Maryam B.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies